Back

Are prediabetes (intermediate hyperglycaemia) and/or obesity a risk factor for cardiometabolic syndrome?

20 February 2026 (10:40 - 11:20)
Organised by: Logo
Seminar Presentation Part of: The importance of risk assessment Cardiovascular Risk Assessment Delegate Premium access EAPC Course : Cardiometabolic Syndrome, Diabetes and Obesity European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Professor Antonio Ceriello

IRCCS - MultiMedica, Milan (Italy)

3 More presentations in this session

Presentation thumbnail
Risk stratification: people at risk of developing obesity/DM
Doctor I. Johansson Bartolini (Stockholm, SE)
Slides Video
Presentation thumbnail
Risk stratification: people with established CVD/DM at risk of disease progress/multimorbidity
Professor A. Abreu (Lisbon, PT)
Video
Presentation thumbnail
Case presentations on risk assessment
Doctor R. Vidal-Perez (A Coruna, ES)
Slides Video

Access the full session

Session thumbnail
The importance of risk assessment

The Event

Event poster

EAPC Course : Cardiometabolic Syndrome, Diabetes and Obesity

20 February 2026 10:40 CET
You may be interested in
thumbnail
Congress Presentation
Prediabetes and risk of cardiovascular disease among 1.3 million patients from an integrated health care system
1 September 2025
thumbnail
Congress Presentation
Is there a specific treatment for cardiometabolic syndrome?
31 August 2024
thumbnail
Congress Presentation
impact of different cardiometabolic risk factors in MASLD: rethinking overweight/obesity criteria.
26 April 2024
thumbnail
Congress Presentation
Cardio-renal-metabolic syndrome in a cohort of patients with chronic heart failure: prevalence and prognosis. An analysis of OFFICE IC AR Registry
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources